Advanced search
Publication Cover
Gut Microbes Volume 15, 2023 - Issue 2
Submit an article Journal homepage
3,599
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Diet and gut microbial associations in irritable bowel syndrome according to disease subtype

Yiqing Wanga Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA;b Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USAView further author information
,
Wenjie Maa Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA;b Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USAView further author information
,
Raaj Mehtaa Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA;b Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USAView further author information
,
Long H. Nguyena Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA;b Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA;c Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USAView further author information
,
Mingyang Songa Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA;b Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA;d Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA;e Department of Nutrition, Harvard T.H. Chan School of Public Health, 677 Huntington Avenue, Boston, MA, USAView further author information
,
David A. Drewa Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA;b Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USAView further author information
,
Francesco Asnicarf Department of Cellular, Computational and Integrative Biology, University of Trento, Trento, ItalyView further author information
,
Curtis Huttenhowerc Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA;g Broad Institute of MIT and Harvard, Cambridge, MA, USAView further author information
,
Nicola Segataf Department of Cellular, Computational and Integrative Biology, University of Trento, Trento, Italy;h European Institute of Oncology Scientific Institute for Research, Hospitalization and Healthcare, Milan, ItalyView further author information
,
Jonathan Wolfi Zoe Ltd, London, UKView further author information
,
Tim Spectorj Department of Twin Research, King’s College London, London, UKView further author information
,
Sarah Berryk Department of Nutritional Sciences, King’s College London, London, UKView further author information
,
Kyle Stallera Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA;b Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USAView further author information
&
Andrew T. Chana Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA;b Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA;e Department of Nutrition, Harvard T.H. Chan School of Public Health, 677 Huntington Avenue, Boston, MA, USA;l Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, USACorrespondence[email protected]
View further author information
 show all
Article: 2262130 | Received 30 Jun 2023, Accepted 15 Sep 2023, Published online: 02 Oct 2023

References

  • Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(10):908–13. doi:10.1016/S2468-1253(20)30217-X.
  • Kibune-Nagasako C, García-Montes C, Silva-Lorena SL, Aparecida-Mesquita M. Irritable bowel syndrome subtypes: clinical and psychological features, body mass index and comorbidities. Rev Esp Enferm Dig. 2016;108(2):59–64. doi:10.17235/reed.2015.3979/2015.
  • Choghakhori R, Abbasnezhad A, Hasanvand A, Amani R. Inflammatory cytokines and oxidative stress biomarkers in irritable bowel syndrome: association with digestive symptoms and quality of life. Cytokine. 2017;93:34–43. doi:10.1016/j.cyto.2017.05.005.
  • Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. Jama. 2015;313(9):949–958. doi:10.1001/jama.2015.0954.
  • Melchior C, Douard V, Coëffier M, Gourcerol G. Fructose and irritable bowel syndrome. Nutr Res Rev. 2020;33(2):235–243. doi:10.1017/S0954422420000025.
  • Staudacher HM, Whelan K. The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS. Gut. 2017;66(8):1517–1527. doi:10.1136/gutjnl-2017-313750.
  • Bijkerk C, De Wit N, Muris J, Whorwell P, Knottnerus J, Hoes A. Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial. Bmj. 2009;339(aug27 2):b3154–b3154. doi:10.1136/bmj.b3154.
  • Vich Vila A, Imhann F, Collij V, Jankipersadsing SA, Gurry T, Mujagic Z, Kurilshikov A, Bonder MJ, Jiang X, Tigchelaar EF, et al. Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome. Sci Transl Med. 2018;10(472):eaap8914. doi:10.1126/scitranslmed.aap8914.
  • Mars RA, Yang Y, Ward T, Houtti M, Priya S, Lekatz HR, Tang X, Sun Z, Kalari KR, Korem T, et al. Longitudinal multi-omics reveals subset-specific mechanisms underlying irritable bowel syndrome. Cell. 2020;182(6):1460–73. e17. doi:10.1016/j.cell.2020.08.007.
  • Crouzet L, Gaultier E, Del’homme C, Cartier C, Delmas E, Dapoigny M, Fioramonti J, Bernalier-Donadille A. The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota. Neurogastroent Motil. 2013;25(4):e272–e282. doi:10.1111/nmo.12103.
  • De Palma G, Lynch MD, Lu J, Dang VT, Deng Y, Jury J, Umeh G, Miranda PM, Pigrau Pastor M, Sidani S, et al. Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice. Sci Transl Med. 2017;9(379):eaaf6397. doi:10.1126/scitranslmed.aaf6397.
  • McKenzie Y, Thompson J, Gulia P, Lomer M. British dietetic association systematic review of systematic reviews and evidence‐based practice guidelines for the use of probiotics in the management of irritable bowel syndrome in adults (2016 update). J Hum Nutr Diet. 2016;29(5):576–592. doi:10.1111/jhn.12386.
  • Jeffery IB, Das A, O’Herlihy E, Coughlan S, Cisek K, Moore M, Bradley F, Carty T, Pradhan M, Dwibedi C, et al. Differences in fecal microbiomes and metabolomes of people with vs without irritable bowel syndrome and bile acid malabsorption. Gastroenterology. 2020;158(4):1016–28. e8. doi:10.1053/j.gastro.2019.11.301.
  • Pittayanon R, Lau JT, Yuan Y, Leontiadis GI, Tse F, Surette M, Moayyedi P. Gut microbiota in patients with irritable bowel syndrome—a systematic review. Gastroenterology. 2019;157(1):97–108. doi:10.1053/j.gastro.2019.03.049.
  • Hungin A, Whorwell P, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects. Aliment Pharmacol Ther. 2003;17(5):643–650. doi:10.1046/j.1365-2036.2003.01456.x.
  • El-Sayed AS, Shindia AA. PLP-Dependent Enzymes: a Potent Therapeutic Approach for Cancer and Cardiovascular Diseases. In: Targets Gene Ther. United Kingdom: IntechOpen; 2011. p. 119–146.
  • Dreyer MK, Schulz GE. Catalytic mechanism of the metal-dependent fuculose aldolase from Escherichia colias derived from the structure. J Mol Biol. 1996;259(3):458–466. doi:10.1006/jmbi.1996.0332.
  • Garber JM, Hennet T, Szymanski CM. Significance of fucose in intestinal health and disease. Mol Microbiol. 2021;115(6):1086–1093. doi:10.1111/mmi.14681.
  • McGovern DP, Jones MR, Taylor KD, Marciante K, Yan X, Dubinsky M, Ippoliti A, Vasiliauskas E, Berel D, Derkowski C, et al. Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn’s disease. Hum Mol Genet. 2010;19(17):3468–3476. doi:10.1093/hmg/ddq248.
  • Yang J, Deng Y, Chu H, Cong Y, Zhao J, Pohl D, Misselwitz B, Fried M, Dai N, Fox M, et al. Prevalence and presentation of lactose intolerance and effects on dairy product intake in healthy subjects and patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2013;11(3):262–8. e1. doi:10.1016/j.cgh.2012.11.034.
  • Dashnyam P, Mudududdla R, Hsieh T-J, Lin T-C, Lin H-Y, Chen P-Y, Hsu C-Y, Lin C-H. β-glucuronidases of opportunistic bacteria are the major contributors to xenobiotic-induced toxicity in the gut. Sci Rep. 2018;8(1):16372. doi:10.1038/s41598-018-34678-z.
  • Guthrie L, Gupta S, Daily J, Kelly L. Human microbiome signatures of differential colorectal cancer drug metabolism. npj Biofilm Microbio. 2017;3(1):27. doi:10.1038/s41522-017-0034-1.
  • Lin XB, Farhangfar A, Valcheva R, Sawyer MB, Dieleman L, Schieber A, Gänzle MG, Baracos V. The role of intestinal microbiota in development of irinotecan toxicity and in toxicity reduction through dietary fibres in rats. PloS One. 2014;9(1):e83644. doi:10.1371/journal.pone.0083644.
  • Lopez-Siles M, Duncan SH, Garcia-Gil LJ, Martinez-Medina M. Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics. ISME J. 2017;11(4):841–852. doi:10.1038/ismej.2016.176.
  • Martín R, Miquel S, Chain F, Natividad JM, Jury J, Lu J, Sokol H, Theodorou V, Bercik P, Verdu EF, et al. Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model. BMC Microbiol. 2015;15(1):1–12. doi:10.1186/s12866-015-0400-1.
  • Coates MD, Johnson AC, Greenwood‐van Meerveld B, Mawe GM. Effects of serotonin transporter inhibition on gastrointestinal motility and colonic sensitivity in the mouse. Neurogastroent Motil. 2006;18(6):464–471. doi:10.1111/j.1365-2982.2006.00792.x.
  • Miquel S, Martín R, Lashermes A, Gillet M, Meleine M, Gelot A, Eschalier A, Ardid D, Bermúdez-Humarán LG, Sokol H, et al. Anti-nociceptive effect of Faecalibacterium prausnitzii in non-inflammatory IBS-like models. Sci Rep. 2016;6(1):1–8. doi:10.1038/srep19399.
  • Canani RB, Di Costanzo M, Leone L, Pedata M, Meli R, Calignano A. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol: WJG. 2011;17(12):1519. doi:10.3748/wjg.v17.i12.1519.
  • Banasiewicz T, Krokowicz Ł, Stojcev Z, Kaczmarek B, Kaczmarek E, Maik J, Marciniak R, Krokowicz P, Walkowiak J, Drews M, et al. Microencapsulated sodium butyrate reduces the frequency of abdominal pain in patients with irritable bowel syndrome. Colorectal Dis. 2013;15(2):204–209. doi:10.1111/j.1463-1318.2012.03152.x.
  • Sonnenburg ED, Sonnenburg JL. Starving our microbial self: the deleterious consequences of a diet deficient in microbiota-accessible carbohydrates. Cell Metab. 2014;20(5):779–786. doi:10.1016/j.cmet.2014.07.003.
  • Armstrong HK, Bording-Jorgensen M, Santer DM, Zhang Z, Valcheva R, Rieger AM, Sung-Ho Kim J, Dijk SI, Mahmood R, Ogungbola O, et al. Unfermented β-fructan fibers fuel inflammation in select inflammatory bowel disease patients. Gastroenterology. 2023;164(2):228–240. doi:10.1053/j.gastro.2022.09.034.
  • Zhang Y, Yu X, Yu E, Wang N, Cai Q, Shuai Q, Yan F, Jiang L, Wang H, Liu J, et al. Changes in gut microbiota and plasma inflammatory factors across the stages of colorectal tumorigenesis: a case-control study. BMC Microbiol. 2018;18(1):1–10. doi:10.1186/s12866-018-1232-6.
  • Zhang J, He Y, Xia L, Yi J, Wang Z, Zhao Y, Song X, Li J, Liu H, Liang X, et al. Expansion of colorectal cancer biomarkers based on gut bacteria and viruses. Cancers. 2022;14(19):4662. doi:10.3390/cancers14194662.
  • Mayneris-Perxachs J, Castells-Nobau A, Arnoriaga-Rodríguez M, Martin M, de la Vega-Correa L, Zapata C, Burokas A, Blasco G, Coll C, Escrichs A, et al. Microbiota alterations in proline metabolism impact depression. Cell Metab. 2022;34(5):681–701. e10. doi:10.1016/j.cmet.2022.04.001.
  • Noble EE, Olson CA, Davis E, Tsan L, Chen Y-W, Schade R, Liu C, Suarez A, Jones RB, de La Serre C, et al. Gut microbial taxa elevated by dietary sugar disrupt memory function. Transl Psychiatry. 2021;11(1):1–16. doi:10.1038/s41398-021-01309-7.
  • Berry SE, Valdes AM, Drew DA, Asnicar F, Mazidi M, Wolf J, Capdevila J, Hadjigeorgiou G, Davies R, Al Khatib H, et al. Human postprandial responses to food and potential for precision nutrition. Nat Med. 2020;26(6):964–973. doi:10.1038/s41591-020-0934-0.
  • Ford AC, Bercik P, Morgan DG, Bolino C, Pintos–Sanchez MI, Moayyedi P. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gastroenterology. 2013;145(6):1262–70. e1. doi:10.1053/j.gastro.2013.08.048.
  • Asnicar F, Berry SE, Valdes AM, Nguyen LH, Piccinno G, Drew DA, Leeming E, Gibson R, Le Roy C, Khatib HA, et al. Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals. Nat Med. 2021;27(2):321–332. doi:10.1038/s41591-020-01183-8.
  • Quince C, Walker AW, Simpson JT, Loman NJ, Segata N. Shotgun metagenomics, from sampling to analysis. Nat Biotechnol. 2017;35(9):833–844. doi:10.1038/nbt.3935.
  • Truong DT, Franzosa EA, Tickle TL, Scholz M, Weingart G, Pasolli E, Tett A, Huttenhower C, Segata N. MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nat Methods. 2015;12(10):902–903. doi:10.1038/nmeth.3589.
  • Franzosa EA, McIver LJ, Rahnavard G, Thompson LR, Schirmer M, Weingart G, Lipson KS, Knight R, Caporaso JG, Segata N, et al. Species-level functional profiling of metagenomes and metatranscriptomes. Nat Methods. 2018;15(11):962–968. doi:10.1038/s41592-018-0176-y.
  • Bingham SA, Welch AA, McTaggart A, Mulligan AA, Runswick SA, Luben R, Oakes S, Khaw KT, Wareham N, Day NE, et al. Nutritional methods in the European prospective investigation of cancer in Norfolk. Public Health Nutr. 2001;4(3):847–858. doi:10.1079/PHN2000102.
  • Mulligan AA, Luben RN, Bhaniani A, Parry-Smith DJ, O’Connor L, Khawaja AP, Forouhi NG, Khaw K-T. A new tool for converting food frequency questionnaire data into nutrient and food group values: FETA research methods and availability. BMJ Open. 2014;4(3):e004503. doi:10.1136/bmjopen-2013-004503.
  • Frankenfield DC, Muth ER, Rowe WA. The Harris-Benedict studies of human basal metabolism: history and limitations. J Am Diet Assoc. 1998;98(4):439–445. doi:10.1016/S0002-8223(98)00100-X.
  • Oksanen J, Kindt R, Legendre P, O’Hara B, Stevens M, Oksanen M, Suggests MA. The vegan package: community ecology package. R Package Version, 2007;1:15–1.
  • Mallick H, Rahnavard A, McIver LJ, Ma S, Zhang Y, Nguyen LH, Tickle TL, Weingart G, Ren B, Schwager EH, et al. Multivariable association discovery in population-scale meta-omics studies. PLoS Comput Biol. 2021;17(11):e1009442. doi:10.1371/journal.pcbi.1009442.
  • Ghazi AR, Sucipto K, Rahnavard G, Franzosa EA, McIver LJ, Lloyd-Price J, Schwager E, Weingart G, Moon YS, Morgan XC, et al. High-sensitivity pattern discovery in large, paired multi-omic datasets. bioRxiv. 2021;38(Supplement_1):i378–85.
  • Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, Blondel M, Prettenhofer P, Weiss R, Dubourg V, et al. Scikit-learn: machine learning in Python. J Mach Learn Res. 2011;12:2825–2830.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.